What is the appropriate dose of permethrin 5% cream for a 4-year-old child with probable scabies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment of Scabies in a 4-Year-Old Child

For a 4-year-old child with probable scabies, apply permethrin 5% cream to all areas of the body from head to toe (including scalp, neck, temple, and forehead) and wash off after 8-14 hours. 1, 2

Dosing Specifics

  • Amount needed: Approximately 30 grams is sufficient for an average adult; use proportionally less for a 4-year-old child based on body surface area 2
  • Application: Single overnight application is generally curative 2
  • Critical difference for young children: Unlike adults where treatment is "neck down," infants and young children MUST have the cream applied to the scalp, hairline, temple, forehead, and face since scabies commonly infests these areas in this age group 1, 2

Why Permethrin is the Clear Choice

Permethrin is specifically recommended as first-line therapy for infants and young children 1. The CDC guidelines explicitly state "Infants and young children should be treated with permethrin" 1. This recommendation is based on:

  • Superior safety profile: Only 2% or less systemic absorption 2
  • Proven efficacy: 89% cure rate at 4 weeks in children 2 months to 5 years 3
  • Rapid symptom relief: Better improvement in lesion count and pruritus within the first week compared to oral alternatives 4

What NOT to Use

Lindane is absolutely contraindicated in children under 10 years of age due to risk of seizures and CNS toxicity 1, 5. The older guidelines that allowed lindane in children over 2 years have been superseded by the 2015 CDC guidelines that raised the age restriction to under 10 years 1.

Ivermectin should not be used as first-line therapy in a 4-year-old because:

  • Children under 10 years should not receive lindane, and while ivermectin is safer, permethrin remains preferred 1
  • Limited data in young children under 15 kg 4
  • Slower onset of action compared to permethrin 4

Practical Application Instructions

  1. Timing: Apply at bedtime
  2. Technique: Massage thoroughly into ALL skin surfaces including between fingers and toes, under nails, in skin folds
  3. Duration: Leave on for 8-14 hours (overnight)
  4. Removal: Wash off in the morning with warm (not hot) water 5
  5. Clothing/bedding: Machine wash and dry on hot cycle or remove from body contact for 72 hours 1

Follow-Up and Retreatment

  • Expect persistent itching for several weeks after successful treatment—this is NOT treatment failure 1, 2
  • Reassess at 14 days: Only retreat if living mites are demonstrated 2
  • Treat all household contacts simultaneously to prevent reinfection 1
  • One application is generally curative; demonstrable living mites after 14 days indicate need for retreatment 2

Common Pitfall to Avoid

The most critical error is failing to treat the head and face in young children. Many providers mistakenly apply the "neck down" rule used in adults, but this leads to treatment failure in children under 5 years because scabies commonly affects the scalp and face in this age group 1, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.